Nickan Research Institute Journal of Renal Endocrinology 2423-6438 9 1 2023 01 01 Onco-hypertension; a collaboration among oncologists, nephrologists and cardiologists e25098 e25098 10.34172/jre.2023.25098 EN Sara Dehghan https://orcid.org/0000-0002-0042-1900 Journal Article 10.34172/jre.2023.25098 2023 03 21 2023 06 10 It is essential to manage hypertension in cancer patients because uncontrolled high blood pressure can increase the risk of cardiovascular complications and negatively impact overall health. We searched PubMed, Web of Science, EBSCO, Scopus, Google Scholar, Directory of Open Access Journals (DOAJ), and Embase, using keywords including; hypertension, onco-hypertension, and Neoplasms; and found that several factors can contribute to the development of onco-hypertension, including certain types of cancer, chemotherapy drugs, targeted therapies, and hormonal treatments. Favorable cooperation of multi-specialists in this disease treatment can lead to better and more optimal treatment management for these patients.